-

AVI Raises Concerns Over Fujitec’s Independent Directors, Questioning Whether They Are Acting in the Best Interests of Shareholders

LONDON--(BUSINESS WIRE)--Asset Value Investors (“AVI”) calls into question the credibility of Fujitec’s current Board of Directors following its failure to hold former President Takakazu Uchiayma to account for decades of related-party transactions and after the debacle at Fujitec’s AGM where, despite shareholders not voting for his re-election, Takakazu Uchiayma was allowed to continue leading the Company as Chairman.

AVI has been a shareholder in Fujitec for almost four years, launching a public campaign in May 2020 titled “Taking Fujitec to the Next Level”. Since the launch of the campaign, Fujitec has undertaken numerous improvements, including the abolishment of an anti-takeover measure, improved shareholder returns, and efforts to standardise production. These actions have led, at least in part, to Fujitec’s +79% share price increase following the launch of AVI’s public campaign in May 2020.

However, Fujitec’s response to legitimate concerns raised by Oasis Management regarding related-party transactions has fallen short of basic standards of good corporate governance. Despite the Board’s efforts to exonerate Mr Uchiyama of any wrongdoing, AVI remains entirely unconvinced that the numerous related-party transactions taken by Mr Uchiyama and his family do not pose a problem for corporate governance. In recognition of Mr Uchiayma’s repeated involvement in related-party transactions and abuse of power, AVI voted against his reappointment at Fujitec’s 2022 AGM.

Joe Bauernfreund, CEO of AVI, commented: Fujitec has defied the voice of shareholders and circumnavigated the AGM voting process to appoint former President Takakazu Uchiyama as Chairman. This flies in the face of the efforts by the TSE, the Government and regulators to enhance corporate governance.

“Outside directors who were party to the decision to withdraw the motion to reappoint Mr Uchiyama just one hour before the AGM and to reappoint him as Chairman should feel ashamed. As outside representatives, they are there to safeguard the interests of shareholders. We question whether the actions of the outside directors have been taken in the best interests of shareholders and whether they have the credibility to continue in their current positions.”

“As a long-standing shareholder, we have had many fruitful discussions with Fujitec representatives over the past years but we are alarmed by recent developments. Shareholders cannot stand by idly while they are being ignored. We are proactively evaluating our next steps.”

ENDS

About AVI
AVI is a London-based investment management company that has been investing in Japanese equities for over 20 years. AVI aims to contribute to the sustainable enhancement of corporate value through dialogue with the management of its portfolio companies.AVI’s investments in Japanese equities amount to approximately JPY 78 billion.

More News From AVI

AVI Calls for Changes at Gerresheimer

LONDON--(BUSINESS WIRE)--Asset Value Investors (“AVI”) has sent an open letter to the Supervisory Board of Gerresheimer AG (“Gerresheimer”) calling for it to make changes to its financial leadership. You can find the published letter here. AVI invested in Gerresheimer in 2024 and manages a 3.5% stake on behalf of institutional clients. Gerresheimer holds a valuable position in the Containment Solutions & Delivery Systems industry, with high barriers to entry and attractive long-term growth...

AVI Urges Wacom To Make Governance Changes

LONDON--(BUSINESS WIRE)--Asset Value Investors Limited (“AVI”) launches a campaign calling for Wacom Corporation (“Wacom”) to be more conscious of the capital market, and announces that AVI has submitted shareholder proposals ahead of Wacom’s upcoming AGM in June. AVI has published a detailed presentation on a dedicated website. AVI invested in Wacom in August 2021 and has sought to engage in dialogue with the company as the largest shareholder, sending letters and presentations with the aim of...

Asset Value Investors Urges Rohto Pharmaceutical to Focus on Core Businesses and Engage With Shareholders More Constructively

LONDON--(BUSINESS WIRE)--Asset Value Investors Limited (‘AVI’) launches a campaign calling for Rohto Pharmaceutical (‘Rohto’) to focus on its core businesses rather than allocating resources to the unsuccessful regenerative medicine business, and to engage with shareholders more constructively to comply with the Tokyo Stock Exchange’s (‘TSE’) request for management that is conscious of the cost of capital and stock price. A detailed presentation can be found here. Since AVI started investing in...
Back to Newsroom